反応式
[C:1]([O:4][C:5]1[C:21]([CH2:22][N:23]([CH2:32][C:33]([O:35][C:36]([CH3:39])([CH3:38])[CH3:37])=[O:34])[CH2:24][C:25]([O:27][C:28]([CH3:31])([CH3:30])[CH3:29])=[O:26])=[CH:20][C:8]([C:9](C2C=CC=C(C(O)=O)C=2)=[O:10])=[CH:7][C:6]=1[CH2:40][N:41]([CH2:50][C:51]([O:53][C:54]([CH3:57])([CH3:56])[CH3:55])=[O:52])[CH2:42][C:43]([O:45][C:46]([CH3:49])([CH3:48])[CH3:47])=[O:44])(=[O:3])[CH3:2].C(N1[C:72]2[C:67](=[CH:68][CH:69]=[CH:70][CH:71]=2)[CH:66]=[CH:65][CH:64]1[O:73][CH2:74]C)(OCC)=O.N[C@H](C(O)=O)C[C:79]1[CH:86]=[C:84]([I:85])[C:83]([O:87][C:88]2[CH:95]=[C:93]([I:94])[C:92]([OH:96])=[C:90]([I:91])[CH:89]=2)=[C:81]([I:82])[CH:80]=1.[O:100]1CCCC1>>[C:1]([O:4][C:5]1[C:21]([CH2:22][N:23]([CH2:32][C:33]([O:35][C:36]([CH3:38])([CH3:37])[CH3:39])=[O:34])[CH2:24][C:25]([O:27][C:28]([CH3:29])([CH3:30])[CH3:31])=[O:26])=[CH:20][C:8]([C:9]([C:71]2[CH:70]=[CH:69][CH:68]=[C:67]([CH2:66][CH:65]([C:64]([O:73][CH3:74])=[O:100])[C:79]3[CH:86]=[C:84]([I:85])[C:83]([O:87][C:88]4[CH:89]=[C:90]([I:91])[C:92]([OH:96])=[C:93]([I:94])[CH:95]=4)=[C:81]([I:82])[CH:80]=3)[CH:72]=2)=[O:10])=[CH:7][C:6]=1[CH2:40][N:41]([CH2:42][C:43]([O:45][C:46]([CH3:47])([CH3:48])[CH3:49])=[O:44])[CH2:50][C:51]([O:53][C:54]([CH3:55])([CH3:56])[CH3:57])=[O:52])(=[O:3])[CH3:2]参加物
5
反応物 4
生成物 1
実験手順
A mixture of 900 mg of 20 and 0.265 g (1.07 mmol) of 1-carbethoxy-2-ethoxy-1,2-dihydroquinoline (EEDQ) in 20 mL of dry tetrahydrofuran was stirred for 30 minutes and 0.85 g (1.07 mmol) of the methyl ester of thyroxine was added. The mixture was stirred overnight. The reaction mixture was purified by gel permeation chromatography using tetrahydrofuran as the solvent, giving 630 mg of material which showed an NMR spectrum which was consistent with structure 21.
後処理
- stirringThe mixture was stirred overnight
- customThe reaction mixture was purified by gel permeation chromatography
出典と根拠
- ORDレコード
- ord-7454a9445f7f41348a67ce5c19ea6fd0
- 出典データセット
- uspto-grants-1989_01
- 特許番号
- US04801722
関連ノート
読み込み中…